These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29441493)
1. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. Kolovos S; Bosmans JE; Riper H; Chevreul K; Coupé VMH; van Tulder MW Pharmacoecon Open; 2017 Sep; 1(3):149-165. PubMed ID: 29441493 [TBL] [Abstract][Full Text] [Related]
2. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. Chhatwal J; He T; Lopez-Olivo MA Pharmacoeconomics; 2016 Jun; 34(6):551-67. PubMed ID: 26748919 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review. Di Tanna GL; Bychenkova A; O'Neill F; Wirtz HS; Miller P; Ó Hartaigh B; Globe G Pharmacoeconomics; 2019 Mar; 37(3):359-389. PubMed ID: 30596210 [TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170 [TBL] [Abstract][Full Text] [Related]
6. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100 [TBL] [Abstract][Full Text] [Related]
7. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
8. Systematic assessment of decision-analytic models for chronic myeloid leukemia. Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259 [TBL] [Abstract][Full Text] [Related]
9. A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources. Haji Ali Afzali H; Karnon J; Gray J Pharmacoeconomics; 2012 Jun; 30(6):461-82. PubMed ID: 22462694 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts. Griffiths UK; Anigbogu B; Nanchahal K Appl Health Econ Health Policy; 2012 May; 10(3):145-62. PubMed ID: 22439628 [TBL] [Abstract][Full Text] [Related]
11. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis. Hawton A; Shearer J; Goodwin E; Green C Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055 [TBL] [Abstract][Full Text] [Related]
12. Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients. Degeling K; Franken MD; May AM; van Oijen MGH; Koopman M; Punt CJA; IJzerman MJ; Koffijberg H Cancer Epidemiol; 2018 Dec; 57():60-67. PubMed ID: 30317148 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of group psychotherapy for depression in Uganda. Siskind D; Baingana F; Kim J J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302 [TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis. Kuukasjärvi P; Räsänen P; Malmivaara A; Aronen P; Sintonen H Int J Technol Assess Health Care; 2007; 23(4):473-9. PubMed ID: 17937836 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207 [TBL] [Abstract][Full Text] [Related]
16. A systematic and critical review of model-based economic evaluations of pharmacotherapeutics in patients with bipolar disorder. Mohiuddin S Appl Health Econ Health Policy; 2014 Aug; 12(4):359-72. PubMed ID: 24838515 [TBL] [Abstract][Full Text] [Related]
17. Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations. Hernandez L; O'Donnell M; Postma M Pharmacoeconomics; 2018 Oct; 36(10):1223-1252. PubMed ID: 29971666 [TBL] [Abstract][Full Text] [Related]
18. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136 [TBL] [Abstract][Full Text] [Related]